CRSP - CRISPR Therapeutics AG

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts14141314
Avg. Estimate-0.96-1.22-4.6-5.23
Low Estimate-1.32-1.41-5.34-7.06
High Estimate-0.76-0.95-3.85-3.83
Year Ago EPS-1.012.41.17-4.6
Revenue EstimateCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
No. of Analysts11111113
Avg. Estimate17.5M2.1M16.93M16.61M
Low EstimateN/AN/AN/AN/A
High Estimate25M13.8M42.4M90M
Year Ago Sales3.94MN/A289.59M16.93M
Sales Growth (year/est)344.20%N/A-94.20%-1.90%
Earnings History6/29/20199/29/201912/30/20193/30/2020
EPS Est.-0.9-0.95-0.63-1.05
EPS Actual-1.012.40.51-1.15
Difference-0.113.351.14-0.1
Surprise %-12.20%352.60%181.00%-9.50%
EPS TrendCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Current Estimate-0.96-1.22-4.6-5.23
7 Days Ago-0.96-1.22-4.6-5.23
30 Days Ago-0.96-1.22-4.63-5.21
60 Days Ago-1.03-1.2-4.65-5.16
90 Days Ago-1.12-1.12-4.51-4.96
EPS RevisionsCurrent Qtr. (Jun 2020)Next Qtr. (Sep 2020)Current Year (2020)Next Year (2021)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/A1N/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesCRSPIndustrySector(s)S&P 500
Current Qtr.5.00%N/AN/AN/A
Next Qtr.-150.80%N/AN/AN/A
Current Year-493.20%N/AN/AN/A
Next Year-13.70%N/AN/AN/A
Next 5 Years (per annum)N/AN/AN/AN/A
Past 5 Years (per annum)N/AN/AN/AN/A